Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Eyepoint › Federated Hermes, Inc. cut its EYPT stake below 5% (1.6%) Fund moves
Stake · was 8.0%
Shares owned
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Oct 31, 2026
Reporting period Not applicable
Filed with the SEC Nov 4, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001623632-26-001650
Data quality Verified: identifiers matched exactly
Around the same time Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Oct 7, 2026 5% stake Federated Hermes, Inc. reported a passive stake (13G) of 8.0% Oct 17, 2026 Company filing · Form 8-K · Results, Restructuring Announced job cuts, closures or a restructuring, and reported its results (and 1 more item) “On October 17, 2026, following review of topline results from LUCIA, the second pivotal Phase 3 clinical trial evaluating DURAVYU for the treatment of wet age-related macular degeneration (wet AMD), the Board of Directors of the Company approved a strategic prioritization plan (the “Prioritization”) designed to reduce operating expenses and focus resources on the Company’s late-stage program for DURAVYU in…” Oct 27, 2026 5% stake TANG CAPITAL MANAGEMENT, LLC reported a passive stake (13G) of 9.6% Oct 30, 2026 5% stake Vanguard Capital Management reported a passive stake (13G) of 5.0% What came next Nov 4, 2026 5% stake Federated Hermes, Inc. reported a passive stake (13G) of 1.6% Nov 12, 2026 Company filing · Form 8-K · Results Reported its results Nov 16, 2026 5% stake Cormorant Asset Management, LP reported a passive stake (13G) of 6.7% Nov 16, 2026